Oxford COVID-19 Vaccine Up to 90% Effective, Only Half-Dose Needed

HNGN

Published

The Oxford/AstraZeneca potential COVID-19 vaccine's late-stage trial results are deemed as "intriguing." It will be further probed how an initial half-dose of the shot offers more protection.

Full Article